• Can We End Epidemics?

  • 著者： Foreign Policy
  • ポッドキャスト

Can We End Epidemics?

著者： Foreign Policy
無料で聴く

  • サマリー

  • Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
    続きを読む 一部表示
activate_samplebutton_t1
エピソード
  • Can We End Epidemics? Trailer

    Can We End Epidemics? Trailer
    2024/06/05
    Is it possible to end HIV and global health epidemics by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
    続きを読む 一部表示
    1 分
  • Putting People First 

    Putting People First 
    2024/06/05
    The United Nations says the world could end AIDS as a public health threat by 2030, but what does that mean? And with less than six years to go, how attainable is this target? In this episode, host Henry Bonsu is joined by Anwar Ogrm, a grassroots trans activist who is the movement-building program lead at Global Action for Trans Equality, and Nneka Nwokolo, the global head of patient engagement at ViiV Healthcare and an honorary consultant physician in HIV and sexual health at Chelsea and Westminster Hospital in London. They discuss how people and communities must be at the heart of public health responses to end infectious disease. Unfortunately, all too often voices go unheard, efforts are inadequately resourced, and there is an imbalance of power fueled by inadequate access to financial and other important resources as well as access to spaces where life-changing decisions are made, including public policy and laws that directly impact people’s lives. But, as this conversation proves, tapping into the knowledge within and between communities is essential for the programs they develop, their advocacy, and the ways they organize, mobilize, and campaign to ensure people and communities are not left behind. Glossary of terms used this season: https://foreignpolicy.com/podcasts/can-we-end-epidemics/
    続きを読む 一部表示
    30 分
  • Dismantling Disparities 

    Dismantling Disparities 
    2024/06/05
    It’s not just infectious diseases that drive epidemics and pandemics; health inequalities can seriously stymie any progress. In this episode of Can We End Epidemics? host Henry Bonsu joins Oni Blackstock, a primary care and HIV physician and founder of the group Health Justice, Amanita Calderón-Cifuentes, an HIV research and advocacy officer for Transgender Europe, and Annemiek de Ruiter, ViiV Healthcare’s vice president and head of global medical sciences, to ask how poverty, racism, homophobia, transphobia, stigma, and all forms of discrimination, including criminalization, drive inadequate access to testing, prevention, treatment, and care, fueling epidemics. They discuss how policymakers, innovators, and community pioneers could address disparities by improving access to information, education, services, innovation, and health technologies for people and communities. Glossary of terms used this season: https://foreignpolicy.com/podcasts/can-we-end-epidemics/
    続きを読む 一部表示
    31 分

あらすじ・解説

Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
政治学
続きを読む 一部表示

Can We End Epidemics?に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。